SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Francesca Riva, Oleksii I. Dronov, Dmytro I. Khomenko, Florence Huguet, Christophe Louvet, Pascale Mariani, Marc-Henri Stern, Olivier Lantz, Charlotte Proudhon, Jean-Yves Pierga, Francois-Clement Bidard, Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer, Molecular Oncology, 2016,

    CrossRef

  2. 2
    Azza M. Kamel, Salwa Teama, Amal Fawzy, Mervat El Deftar, Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer, Tumor Biology, 2015,

    CrossRef

  3. 3
    Giulia Siravegna, Alberto Bardelli, Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance, Genome Biology, 2014, 15, 8

    CrossRef

  4. 4
    Nigel Murray, Cancer Biomarkers, 2014,

    CrossRef

  5. 5
    Marcelo L. Wroclawski, Ary Serpa-Neto, Fernando L. A. Fonseca, Oseas Castro-Neves-Neto, Alexandre S. F. L. Pompeo, Marcos T. Machado, Antonio C. L. Pompeo, Auro del Giglio, Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients, Tumor Biology, 2013, 34, 5, 2921

    CrossRef

  6. 6
    Pâmela Oliveira Delgado, Beatriz Costa A. Alves, Flávia de Sousa Gehrke, Renata Kelly Kuniyoshi, Marcelo Langer Wroclavski, Auro Del Giglio, Fernando Luiz Affonso Fonseca, Characterization of cell-free circulating DNA in plasma in patients with prostate cancer, Tumor Biology, 2013, 34, 2, 983

    CrossRef

  7. 7
    Ricardo Moreno, Pamela O Delgado, Patrícia G Coelho, Sarah R Marsicano, Viviane AV Boas, Ligia A Azzalis, Virgínia BC Junqueira, Katya C Rocha, Luiz Carlos de Abreu, Vitor E Valenti, Jefferson Drezzet, Edimar Cristiano Pereira, Fernando LA Fonseca, Lack of reliability of nanotechnology in the of free plasma DNA in samples of patients with prostate cancer, International Archives of Medicine, 2013, 6, 1, 2

    CrossRef

  8. 8
    Wei Shi, Chenglin Lv, Jing Qi, Wei Zhao, Xiujie Wu, Rongrong Jing, Xinhua Wu, Shaoqing Ju, Jian Chen, Prognostic Value of Free DNA Quantification in Serum and Cerebrospinal Fluid in Glioma Patients, Journal of Molecular Neuroscience, 2012, 46, 3, 470

    CrossRef

  9. 9
    Zhaohui Huang, Dong Hua, Yu Hu, Zhihong Cheng, Xike Zhou, Qigen Xie, Qiongyao Wang, Feng Wang, Xiang Du, Yanjun Zeng, Quantitation of Plasma Circulating DNA Using Quantitative PCR for the Detection of Hepatocellular Carcinoma, Pathology & Oncology Research, 2012, 18, 2, 271

    CrossRef

  10. 10
    Michela de Martino, Tobias Klatte, Andrea Haitel, Michael Marberger, Serum cell-free DNA in renal cell carcinoma, Cancer, 2012, 118, 1
  11. 11
    Weijie Chen, Fengfeng Cai, Bei Zhang, Xiao Yan Zhong, Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma, Clinical Chemistry and Laboratory Medicine (CCLM), 2012, 50, 2

    CrossRef

  12. 12
    Chisako Iriyama, Akihiro Tomita, Hideaki Hoshino, Mizuho Adachi-Shirahata, Yoko Furukawa-Hibi, Kiyofumi Yamada, Hitoshi Kiyoi, Tomoki Naoe, Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome, Biochemical and Biophysical Research Communications, 2012, 419, 4, 662

    CrossRef

  13. 13
    Heidi Schwarzenbach, Dave S. B. Hoon, Klaus Pantel, Cell-free nucleic acids as biomarkers in cancer patients, Nature Reviews Cancer, 2011, 11, 6, 426

    CrossRef

  14. 14
    Suyin P. Chin, Joanne L. Dickinson, Adele F. Holloway, Epigenetic regulation of prostate cancer, Clinical Epigenetics, 2011, 2, 2, 151

    CrossRef

  15. 15
    Jörg Ellinger, Stefan C. Müller, Thomas C. Stadler, Andreas Jung, Alexander von Ruecker, Patrick J. Bastian, The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer, Urologic Oncology: Seminars and Original Investigations, 2011, 29, 2, 124

    CrossRef

  16. 16
    J. Ellinger, A. von Rücker, P.J. Bastian, S.C. Müller, Zellfreie DNA im Blut, Der Urologe, 2010, 49, 9, 1131

    CrossRef

  17. 17
    Doriane Gouas, Hong Shi, Pierre Hainaut, The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy, Cancer Letters, 2009, 286, 1, 29

    CrossRef

  18. 18
    Rebecca R. Zachariah, Seraina Schmid, Nicole Buerki, Ramin Radpour, Wolfgang Holzgreve, XiaoYan Zhong, Levels of Circulating Cell-Free Nuclear and Mitochondrial DNA in Benign and Malignant Ovarian Tumors, Obstetrics & Gynecology, 2008, 112, 4, 843

    CrossRef

  19. 19
    M. Fleischhacker, B. Schmidt, Circulating nucleic acids (CNAs) and cancer—A survey, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007, 1775, 1, 181

    CrossRef

  20. 20
    Fuming Sang, Jicun Ren, Comparisons between capillary zone electrophoresis and real-time PCR for quantification of circulating DNA levels in human sera, Journal of Chromatography B, 2006, 838, 2, 122

    CrossRef

  21. 21
    Dean Troyer, Emerging biomarkers in prostate cancer, Aging Health, 2006, 2, 4, 579

    CrossRef